 |
|
Effects of Intravitreal Injection of Bevacizumab or Ranibizumab on Systemic Circulation.
Myung Hun Yoon, Young Jun Kim, So Young Lee, Kang Won Lee, Hee Seung Chin
J Korean Ophthalmol Soc. 2016;57(3):429-437. Published online 2016 Mar 15 DOI: https://doi.org/10.3341/jkos.2016.57.3.429
|
|
Citations to this article as recorded by
 Ocular and systemic vascular endothelial growth factor ligand inhibitor use and nephrotoxicity: an update
Dharshan Rangaswamy, Shankar Prasad Nagaraju, Mohan Varadanayakanahalli Bhojaraja, Shilna Muttickal Swaminathan, Ravindra A. Prabhu, Indu Ramachandra Rao, Srinivas Vinayak Shenoy
International Urology and Nephrology.2024;[Epub] CrossRef Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review
Ramy M. Hanna, Rebecaa S. Ahdoot, Matthew S. Kim, Kenar D. Jhaveri, Kamyar Kalantar-Zadeh, Ira B. Kurtz
Current Opinion in Nephrology & Hypertension.2022; 31(1): 47. CrossRef Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration
Gautam Phadke, Ramy M Hanna, Antoney Ferrey, Everardo Arias Torres, Anjali Singla, Amit Kaushal, Kamyar Kalantar-Zadeh, Ira Kurtz, Kenar D Jhaveri
Clinical Kidney Journal.2021; 14(10): 2158. CrossRef Clinical experience with urgent tube shunt implantation through the ciliary sulcus in phakic eyes
Adam J. Weiner, Yotam Weiner, Melissa L. Severson, Asher Weiner
International Ophthalmology.2019; 39(3): 639. CrossRef Change in Central Macular Thickness after 2.2-mm Microincision Coaxial versus 2.75-mm Small Incision Cataract Surgery
Ye Jin Ahn, Eun Chul Kim
Journal of the Korean Ophthalmological Society.2014; 55(10): 1460. CrossRef
|